WINNIPEG, MB – TheNewswire - November 28, 2023 – DELTA 9 CANNABIS INC. (TSX:DN) (OTC:DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has received a certificate of compliance with Good Agricultural and Collection Practices (GACP) for its Winnipeg based cannabis cultivation and processing facilities.

After a thorough audit process the Company received confirmation from an arm’s length third party certification company that its operations are in compliance with GACP guidelines for starting materials and medicinal products of herbal origin (EMEA 2006, WHO 2002) and within the requirements of international destination countries. The scope of activities includes cannabis cultivation, harvesting, drying, and trimming activities.

“This is a significant milestone for Delta 9, allowing us to expand our international exports of medical cannabis products into new markets and to new customers, said John Arbuthnot, CEO of Delta 9. “This GACP certification confirms the excellence of quality assurance and control systems in place at our cultivation and processing facilities and will allow Delta 9 to participate in the growing demand for Canadian medical use cannabis products globally.”

On February 13, 2023, the Company announced that it completed its first international shipment of bulk cannabis to a customer in Australia, as well as the receipt of several additional export permits from Health Canada. Over the first nine months of 2023 the Company completed multiple shipments of dried cannabis and cannabis extracts totalling approximately $705,000. The Company anticipates that the GACP certification will allow it to expand its international exports in 2024 and take on additional international medical markets outside of Australia.

The GACP certification is valid until November 9, 2025.

For more information contact:

Investor & Media Contact:

Ian Chadsey VP Corporate Affairs

Mobile: 204-898-7722

E-mail: ian.chadsey@delta9.ca

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 95,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTC under the symbol "DLTNF". For more information, please visit www.delta9.ca.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements contained in this release include; a) the Company’s intention to supply medical cannabis products to international customers, and b) the Company’s intention to expand its international cannabis export revenue. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including all risk factors set forth in the annual information form of Delta 9 dated March 31, 2023 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.